BPA Call 36E79725A0011-36C24526N0783
Award Date 7/30/26
Potential Completion Date 8/4/26
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
Not listed Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Belle Isle, FL 32809, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On May 11, 2023, the Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $12,195.72 to Otsuka America Pharmaceutical Inc. for the supply of Jynarque 90mg-30mg tablets. The contract utilizes a firm fixed price structure with no set-aside designation and is scheduled for completion by May 16, 2023. This delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and represents a task order under...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order for Jynarque (tolvaptan) 45mg-15mg to Otsuka America Pharmaceutical Inc. on April 6, 2023, with a ceiling value of $12,224.60 and an ultimate completion date of April 12, 2023. The contract is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) as a firm fixed-price delivery order with no set-aside designation. Performance will take place in Pittsburgh,...
- On March 8, 2024, the Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $12,559.90 to Otsuka America Pharmaceutical Inc. for the supply of Jynarque 90mg/30mg. This firm-fixed price delivery order, with an ultimate completion date of March 15, 2024, will be performed in Pittsburgh, Pennsylvania. The award was issued without a set-aside designation, reflecting Otsuka America Pharmaceutical Inc.'s status as an established large...
- On June 8, 2023, the Department of Veterans Affairs, specifically Veterans Integrated Service Network 5, awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 90mg/30mg tablets with a ceiling value of $12,195.72. This contract is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and utilizes an underlying Blanket Purchase Agreement valued at $83.3 million that enables VA facilities across multiple Integrated Service Networks to procure this...
- Otsuka America Pharmaceutical Inc. was awarded a delivery order by Veterans Integrated Service Network 5 (VISN 5) on June 21, 2024, for the supply of Jynarque (tolvaptan) in 90mg-30mg formulation. This firm fixed-price delivery order has a ceiling value of $12,559.90 and an ultimate completion date of June 24, 2024, with performance to be completed in Pittsburgh, Pennsylvania. The contract does not utilize any set-aside designations. This delivery order is issued under Otsuka America...
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a delivery order to Otsuka America Pharmaceutical Inc. on June 4, 2024, for the supply of Tolvaptan (Jynarque) 45mg/15mg tablets (NDC: 59148-0087-28) with a ceiling value of $12,580.72. This firm fixed-price delivery order, which is set to be completed by July 4, 2024, is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize any small business set-aside...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a $11,413.72 delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 60mg/30mg on December 8, 2022, with completion targeted for December 12, 2022. This firm-fixed-price delivery order was issued without a set-aside designation and is sourced under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant...
- Otsuka America Pharmaceutical Inc. has been awarded a delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 for the supply of Tolvaptan (Jynarque) 45mg/15mg tablets, with a contract ceiling value of $12,580.72. This firm fixed-price delivery order, issued on April 8, 2024, with an ultimate completion date of May 8, 2024, represents a task order against Otsuka America's larger Indefinite Delivery Vehicle with the VA. The contract does not utilize a set-aside...
- Otsuka America Pharmaceutical Inc. was awarded a delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 5 on October 14, 2021, for the supply of Jynarque (tolvaptan) 60mg/30mg pharmaceutical product. This firm-fixed price delivery order, valued at $10,298.57, was completed by October 15, 2021, with performance executed in Riverwoods, Illinois. The award utilized no set-aside designation, reflecting the vendor's status as an established large pharmaceutical...
- Otsuka America Pharmaceutical Inc. received a $10,034.63 delivery order from Veterans Integrated Service Network 9 (VISN 9) on October 20, 2020, for Tolvaptan in two dosage strengths: 15mg (seven units) and 45mg (seven units). The contract is structured as a firm fixed-price delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with performance in Potomac, Maryland and an ultimate completion date of October 27, 2020. No set-aside designation was utilized for this...